Two product lines for pharma. Protocol Safe is a per-trial sponsor-tenant architecture for protocol-aware adverse event attribution where the protocol stays inside the sponsor's own cloud infrastructure; only the attribution signal crosses the boundary. Postmarket Pharmacovigilance Processing is an enterprise platform that uses the same grading engine to process adverse events on approved drugs, with MedDRA coding, E2B(R3) formatting, MedWatch and CIOMS generation, and DSUR and PSUR support. The throughline: the same engine, the same citation discipline, applied across the full drug lifecycle from Phase 1 trial to decades of postmarket surveillance.
More on for pharma sponsors.
- What is Protocol Safe?
- How does Protocol Safe preserve sponsor protocol IP?
- How does Burna AI support postmarket pharmacovigilance?
- What is the postmarket pharmacovigilance volume scale Burna AI is built for?
- How does Burna AI address the 11% oncology death rate attributable to poor adverse event management?